Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
   PubMed Web of Science ®Google Scholar
• Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–1306.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Wieszczy P, Rupinski M, et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology. 2017;153:98–105.
   PubMed Web of Science ®Google Scholar
• Hewitson P, Glasziou P, Irwing L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. London: The Cochrane Collaboration; 2011.
   Google Scholar
• Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015;64:1327–1337.
   PubMed Web of Science ®Google Scholar
• Goede SL, Rabeneck L, van Ballegooijen M, et al. Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening. PLoS One. 2017;12:e0172864.
   PubMed Web of Science ®Google Scholar
• Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49:3049–3054.
   PubMed Web of Science ®Google Scholar
• Burch JA, Soares-Weiser K, St John DJ, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen. 2007;14:132–137.
   PubMed Web of Science ®Google Scholar
• Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev Med. 2012;55:87–92.
   PubMed Web of Science ®Google Scholar
• Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649.
   PubMed Web of Science ®Google Scholar
• Larsen MB, Njor S, Ingeholm P, et al. Effectiveness of colorectal cancer screening in detecting earlier-stage disease-a nationwide cohort study in Denmark. Gastroenterology. 2018;155:99–106.
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: global trends and future challenges. World J Gastroenterol. 2019;25:190–204.
   PubMed Web of Science ®Google Scholar
• Reumkens A, Rondagh EJ, Bakker CM, et al. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol. 2016;111:1092–1101.
   PubMed Web of Science ®Google Scholar
• Mikkelsen EM, Thomsen MK, Tybjerg J, et al. Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program. Clin Epidemiol. 2018;10:1649–1655.
   PubMed Web of Science ®Google Scholar
• The Danish Health Authority. Anbefalinger vedrørende screening for tyk- og endetarmskraeft [in Danish]. Copenhagen, Denmark: The Danish Health Authority; 2012.
   Google Scholar
• Njor SH, Friis-Hansen L, Andersen B, et al. Three years of colorectal cancer screening in Denmark. Cancer Epidemiol. 2018;57:39–44.
   PubMed Web of Science ®Google Scholar
• Danish Colorectal Cancer Screening Database, Annual report. The first 10 months of the first screening round of the national screening programme [in Danish]. 2014. [accessed 2019 Feb 22]. Available from: https://www.sundhed.dk/content/cms/45/61245_dts%C3%A5rsrapport-2014_8-1-16_final_inklbilag.pdf
   Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22–25.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39:30–33.
   PubMed Web of Science ®Google Scholar
• Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39:72–74.
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish cancer registry. Scand J Public Health. 2011;39:42–45.
   PubMed Web of Science ®Google Scholar
• Thomsen MK, Njor SH, Rasmussen M, et al. Validity of data in the Danish colorectal cancer screening database. Clin Epidemiol. 2017;9:105–111.
   PubMed Web of Science ®Google Scholar
• Chiang TH, Chuang SL, Chen SL, et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology. 2014;147:1317–1326.
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–1502.
   PubMed Web of Science ®Google Scholar
• Toes-Zoutendijk E, van Leerdam ME, Dekker E, et al. Real-time monitoring of results during first year of Dutch colorectal cancer screening program and optimization by altering fecal immunochemical test cut-off levels. Gastroenterology. 2017;152:767–775.e2.
   PubMed Web of Science ®Google Scholar
• Segnan N, Patnick J, von Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg, Europe: Publications Office of the European Union; 2010.
   Google Scholar
• Thomsen MK, Rasmussen M, Njor SH, et al. Demographic and comorbidity predictors of adherence to diagnostic colonoscopy in the Danish Colorectal Cancer Screening Program: a nationwide cross-sectional study. Clin Epidemiol. 2018;10:1733–1742.
   PubMed Web of Science ®Google Scholar
• Kirkegaard P, Edwards A, Larsen MB, et al. Waiting for diagnostic colonoscopy: a qualitative exploration of screening participants’ experiences in a FIT-based colorectal cancer screening program. Patient Prefer Adherence. 2018;12:845–852.
   PubMed Web of Science ®Google Scholar
• Astin M, Griffin T, Neal RD, et al. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract. 2011;61:e231–43.
   PubMed Web of Science ®Google Scholar
• Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101:S80–S86.
   PubMed Web of Science ®Google Scholar
• Herrero JM, Vega P, Salve M, et al. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study. BMC Gastroenterol. 2018;18:155.
   PubMed Web of Science ®Google Scholar
• van Dam L, Bretthauer M. Ethical issues in colorectal cancer screening. Best Pract Res Clin Gastroenterol. 2014;28:315–326.
   PubMed Web of Science ®Google Scholar
• Hofmann B. Ethical issues with colorectal cancer screening-a systematic review. J Eval Clin Pract. 2017;23:631–641.
   PubMed Web of Science ®Google Scholar
• Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology. 1987;93:1009–1013.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532.
   PubMed Web of Science ®Google Scholar